share_log

Merck & Co | 4: Statement of changes in beneficial ownership of securities-Officer DeLuca Richard R.

SEC announcement ·  Jan 25 05:11
Summary by Futu AI
Richard R. DeLuca, EVP & President of Merck Animal Health, has completed a purchase of Merck & Co. common stock on January 22, 2024. The transaction involved the acquisition of 23,296 shares at a price of $119.43 per share. Following this transaction, DeLuca directly holds a total of 135,782.983 shares. Additionally, DeLuca has an indirect ownership of 1,230.1758 shares through a 401(k) plan. The total value of the shares acquired in the transaction is approximately $2.78 million.
Richard R. DeLuca, EVP & President of Merck Animal Health, has completed a purchase of Merck & Co. common stock on January 22, 2024. The transaction involved the acquisition of 23,296 shares at a price of $119.43 per share. Following this transaction, DeLuca directly holds a total of 135,782.983 shares. Additionally, DeLuca has an indirect ownership of 1,230.1758 shares through a 401(k) plan. The total value of the shares acquired in the transaction is approximately $2.78 million.
Helpful
Not Helpful

This announcement is a separate document:

Doc 1

The information provided by Futu AI is automatically generated by third-party artificial intelligence (AI) software based on news content. It is only available to users located outside of China mainland.


The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.